CIK 0001644963
- Non-accelerated filer
- Smaller reporting company
AVENUE THERAPEUTICS, INC.
Sign in to watch- Ticker
- ATXI
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474113275
- Phone
- +1 781-652-4500
- Business address
- 1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award 10% owner acquired 52,419 shares (grant or award)
- 4 Grant or award 10% owner acquired 322,225 shares (grant or award)
- 4 Open-market sale 10% owner sold 388,888 shares at $7.71 ($2,999,882)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 69,020 shares (grant or award)
- 4 Grant or award Director acquired 69,020 shares (grant or award)
- 4 Grant or award Director acquired 49,020 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award President, CEO acquired 411,616 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 100,505 shares (grant or award)
- 4 Open-market sale Chief Financial Officer sold 7,160 shares at $1.62 ($11,599)
- 4 Open-market buy Director bought 2,500 shares at $3.99 ($9,975)
Page 2 of 5 · 96 filings